BNP Paribas Financial Markets’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $83.8M | Buy |
395,245
+124,964
| +46% | +$24.5M | 0.03% | 523 |
|
|
2026
Q1 | $53M | Buy |
270,281
+42,224
| +19% | +$8.2M | 0.03% | 655 |
|
|
2025
Q4 | $39.6M | Buy |
228,057
+6,487
| +3% | +$1.18M | 0.02% | 802 |
|
|
2025
Q3 | $42.2M | Sell |
221,570
-25,662
| -10% | -$4.55M | 0.02% | 703 |
|
|
2025
Q2 | $44.4M | Sell |
247,232
-120,098
| -33% | -$20.9M | 0.03% | 632 |
|
|
2025
Q1 | $62.2M | Sell |
367,330
-181,874
| -33% | -$29.9M | 0.04% | 509 |
|
|
2024
Q4 | $82.9M | Sell |
549,204
-198,094
| -27% | -$30.8M | 0.05% | 413 |
|
|
2024
Q3 | $116M | Buy |
747,298
+151,365
| +25% | +$22.6M | 0.08% | 248 |
|
|
2024
Q2 | $81.6M | Buy |
595,933
+69,454
| +13% | +$9.51M | 0.07% | 289 |
|
|
2024
Q1 | $70.1M | Buy |
526,479
+167,623
| +47% | +$21.7M | 0.06% | 334 |
|
|
2023
Q4 | $49.5M | Buy |
358,856
+219,187
| +157% | +$28.8M | 0.06% | 375 |
|
|
2023
Q3 | $17M | Sell |
139,669
-21,384
| -13% | -$2.85M | 0.02% | 671 |
|
|
2023
Q2 | $22.6M | Sell |
161,053
-35,634
| -18% | -$4.91M | 0.03% | 560 |
|
|
2023
Q1 | $27.8M | Buy |
196,687
+67,052
| +52% | +$9.59M | 0.04% | 476 |
|
|
2022
Q4 | $20.3M | Sell |
129,635
-89,974
| -41% | -$12.9M | 0.03% | 653 |
|
|
2022
Q3 | $26.9M | Buy |
219,609
+61,292
| +39% | +$8.07M | 0.04% | 496 |
|
|
2022
Q2 | $21.1M | Buy |
158,317
+1,741
| +1% | +$237K | 0.03% | 550 |
|
|
2022
Q1 | $21.4M | Buy |
156,576
+28,891
| +23% | +$4.03M | 0.03% | 593 |
|
|
2021
Q4 | $22.1M | Sell |
127,685
-62,623
| -33% | -$9.53M | 0.03% | 609 |
|
|
2021
Q3 | $27.7M | Buy |
190,308
+16,128
| +9% | +$2.36M | 0.04% | 478 |
|
|
2021
Q2 | $23M | Buy |
174,180
+6,227
| +4% | +$815K | 0.03% | 591 |
|
|
2021
Q1 | $21.6M | Buy |
167,953
+56,703
| +51% | +$6.99M | 0.03% | 530 |
|
|
2020
Q4 | $13.3M | Sell |
111,250
-15,415
| -12% | -$1.88M | 0.02% | 667 |
|
|
2020
Q3 | $14.5M | Sell |
126,665
-43,434
| -26% | -$5.13M | 0.02% | 634 |
|
|
2020
Q2 | $19.4M | Buy |
170,099
+69,502
| +69% | +$7.37M | 0.03% | 469 |
|
|
2020
Q1 | $8.08M | Buy |
100,597
+76,586
| +319% | +$7.93M | 0.02% | 750 |
|
|
2019
Q4 | $2.56M | Buy |
24,011
+12,005
| +100% | +$1.25M | ﹤0.01% | 1558 |
|
|
2019
Q3 | $1.29M | Sell |
12,006
-27,263
| -69% | -$2.8M | ﹤0.01% | 1727 |
|
|
2019
Q2 | $4M | Sell |
39,269
-32,534
| -45% | -$3.13M | 0.01% | 1137 |
|
|
2019
Q1 | $6.46M | Sell |
71,803
-26,385
| -27% | -$2.29M | 0.01% | 897 |
|
|
2018
Q4 | $8.18M | Buy |
98,188
+4,205
| +4% | +$394K | 0.02% | 727 |
|
|
2018
Q3 | $10.1M | Sell |
93,983
-46,763
| -33% | -$5.13M | 0.02% | 828 |
|
|
2018
Q2 | $15.5M | Buy |
140,746
+87,631
| +165% | +$9.13M | 0.03% | 608 |
|
|
2018
Q1 | $5.33M | Sell |
53,115
-31,344
| -37% | -$3.21M | 0.01% | 964 |
|
|
2017
Q4 | $8.32M | Sell |
84,459
-118,281
| -58% | -$11.2M | 0.01% | 808 |
|
|
2017
Q3 | $19M | Sell |
202,740
-93,893
| -32% | -$9.97M | 0.05% | 364 |
|
|
2017
Q2 | $33M | Buy |
296,633
+97,868
| +49% | +$10.3M | 0.1% | 200 |
|
|
2017
Q1 | $19.5M | Buy |
198,765
+140,780
| +243% | +$13.4M | 0.05% | 377 |
|
|
2016
Q4 | $5.33M | Buy |
57,985
+35,575
| +159% | +$3.07M | 0.03% | 542 |
|
|
2016
Q3 | $1.9M | Sell |
22,410
-8,212
| -27% | -$690K | 0.01% | 740 |
|
|
2016
Q2 | $2.49M | Sell |
30,622
-15,037
| -33% | -$1.15M | 0.01% | 755 |
|
|
2016
Q1 | $3.26M | Sell |
45,659
-26,977
| -37% | -$1.81M | 0.01% | 692 |
|
|
2015
Q4 | $5.17M | Sell |
72,636
-34,750
| -32% | -$2.34M | 0.01% | 610 |
|
|
2015
Q3 | $6.6M | Buy |
107,386
+66,685
| +164% | +$4.66M | 0.02% | 562 |
|
|
2015
Q2 | $2.95M | Sell |
40,701
-15,994
| -28% | -$1.18M | 0.01% | 725 |
|
|
2015
Q1 | $4.36M | Sell |
56,695
-46,178
| -45% | -$3.31M | 0.01% | 651 |
|
|
2014
Q4 | $6.9M | Buy |
102,873
+31,758
| +45% | +$2M | 0.02% | 541 |
|
|
2014
Q3 | $4.32M | Buy |
71,115
+26,800
| +60% | +$1.65M | ﹤0.01% | 775 |
|
|
2014
Q2 | $2.6M | Sell |
44,315
-21,253
| -32% | -$1.24M | ﹤0.01% | 883 |
|
|
2014
Q1 | $3.67M | Sell |
65,568
-4,732
| -7% | -$254K | ﹤0.01% | 746 |
|
|
2013
Q4 | $3.76M | Sell |
70,300
-10,769
| -13% | -$639K | ﹤0.01% | 717 |
|
|
2013
Q3 | $5.01M | Buy |
+81,069
| New | +$4.85M | ﹤0.01% | 690 |
|
Other funds holding DGX
VCM
VPM
BNP Paribas Financial Markets's DGX Position: Q2 2026 in Review
BNP Paribas Financial Markets increased its Quest Diagnostics (DGX) stake by 46% in Q2 2026, buying an estimated $24.5M and bringing the position to 395,245 shares worth $83.8M. The position accounts for 0.03% of the portfolio, ranked #523.
BNP Paribas Financial Markets first reported a position in DGX in Q3 2013 and has held it in 52 quarters since. The position peaked at $116M in Q3 2024. 925 funds tracked by Wall St. Rank hold DGX as of Q2 2026.
- BNP Paribas Financial Markets held 395,245 shares of Quest Diagnostics worth $83.8M as of Q2 2026.
- BNP Paribas Financial Markets bought 124,964 Quest Diagnostics shares in Q2 2026, an estimated $24.5M.
- Quest Diagnostics made up 0.03% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #523 holding.
- BNP Paribas Financial Markets first reported a position in Quest Diagnostics in Q3 2013 and has held it in 52 quarters since.
- BNP Paribas Financial Markets's Quest Diagnostics position peaked at $116M in Q3 2024.
- 925 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.